Brain, Vol. 113, No. 5, 1307-1320, 1990
© 1990 Guarantors of Brain
research-article |
MYELOPATHY ASSOCIATED WITH HUMAN T CELL LYMPHOTROPIC VIRUS TYPE I (HTLV-I) IN NATAL, SOUTH AFRICA
A CLINICAL AND INVESTIGATIVE STUDY IN 24 PATIENTS
1Neurology Unit, Department of Medicine, Faculty of Medicine, University of Natal South Africa 2Department of Virology, Faculty of Medicine, University of Natal South Africa 3Department of Medical Virology, Faculty of Medicine, University of Stellenbosch South Africa
Correspondence to:
Correspondence to: Dr A. I. Bhigiee, Neurology Unit, Wentworth Hospital, Private Bag, Jacobs 4026, South Africa.
Unexplained spastic myelopathy in black (Zulu) patients, similar to that seen in the tropics, has previously been described from Natal, South Africa. Following reports linking the human T cell lymphotropic virus type I (HTLV-I) to spastic myelopathy, we undertook a prospective and retrospective search for HTLV-I antibodies in 36 patients who were labelled as having unexplained myelopathy; 24 (66%) were positive and HTLV-I was isolated from 4 out of the 6 patients whose peripheral blood lymphocytes were cultured. Eighteen (75%) gave a short history (less than 6 months). There was a female preponderance (71%), spinothalamic dysfunction was common (55%) and as many as half were severely disabled (50% wheelchair bound). Routine laboratory studies showed no specific trends apart from hypergammaglobulinaemia and CSF pleocytosis (greater than 5 cells/µl in 66% of patients). The total CSF protein was raised (greater than 0.4 g/l) in 45% of patients. The IgG index was greater than 0.7 in 15 of 19 patients. Conventional myelography did not show any specific abnormalities. Computer assisted myelography was undertaken in 22 patients; 3 showed arachnoiditis and 2 spinal cord atrophy. Periventricular lucencies were seen in 1 of 10 patients who had computed tomography of the head. Nerve conduction studies demonstrated abnormalities in 46% of the patients indicating that subclinical peripheral nerve dysfunction was common. Visual evoked responses were abnormal in only 1 patient but brainstem auditory evoked response studies showed some abnormality in 42% of the patients. The finding of HTLV-I antibodies in a significant number, and the isolation of HTLV-I from the blood in 6 of our black patients with noncompressive myelopathy, represents a substantial clinical advance. Future studies should define more clearly the role of the virus in this disorder.
Received March 6, 1989. Revised September 20, 1989. Accepted September 29, 1989.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S A Cooper, M S. van der Loeff, and G P Taylor The neurology of HTLV-1 infection Practical Neurology, February 1, 2009; 9(1): 16 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Cooper, M Schim van der Loeff, S McConkey, M Cooper, R Sarge-Njie, S Kaye, and H Whittle Neurological morbidity among human T-lymphotropic-virus-type-1-infected individuals in a rural West African population J. Neurol. Neurosurg. Psychiatry, January 1, 2009; 80(1): 66 - 68. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. I. Bhigjee, S. Madurai, P.L.A. Bill, V. Patel, P. Corr, M.N. Naidoo, W.M. Gopaul, A. Smith, and D. York Spectrum of myelopathies in HIV seropositive South African patients Neurology, July 24, 2001; 57(2): 348 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Cabre, D Smadja, A Cabié, and C R J C Newton NEUROLOGICAL ASPECTS OF TROPICAL DISEASE: HTLV-1 and HIV infections of the central nervous system in tropical areas J. Neurol. Neurosurg. Psychiatry, May 1, 2000; 68(5): 550 - 557. [Full Text]
|
|
|
|
 |
|
 A. Gessain and O. Gout Chronic Myelopathy Associated with Human T-Lymphotropic Virus Type I (HTLV-I) Ann Intern Med, December 1, 1992; 117(11): 933 - 946. [Abstract] [PDF]
|
|